Category Archives: Diabetes Complications

Diabetes and Shortened Lifespan: “How Bad Is It, Doc?”

Diabetes mellitus for years has been linked with cardiovascular disease such as heart failure and coronary heart disease (blocked arteries in the heart, and the leading cause of death in the Western world).  How scared should diabetics be?

An article  in the Archives of Internal Medicine gives us one answer.

Researchers from the Netherlands and Harvard examined medical records of 5,209 people (mostly white, 64% men) enrolled in the Framingham (Massachusetts, USA) Heart Study.  This cohort has been examined every other year for more than 46 years. 

Study subjects who had diabetes at age 50 were identified; health outcomes going forward were then analyzed, with particular attention to lifespan and cardiovascular disease.  “Cardiovascular disease” in this context means coronary heart disease, stroke, congestive heart failure, intermittent claudication (leg pain during exertion caused by blocked arteries), and transient ischemic attack (stroke-like symptoms that resolve within 24 hours).

Results

Compared to those in the cohort free of diabetes, having diabetes at age 50 more than doubled the risk of developing cardiovascular disease for both women and men. 

Compared to those without diabetes, having both cardiovascular disease and diabetes approximately doubled the risk of dying, regardless of sex.

Compared to those without diabetes, women and men with diabetes at age 50 died 7 or 8 years earlier, on average.

[Specific causes of death were not reported.]

Take-Home Points

We’d likely see longer lifespans and less cardiovascular disease if we could prevent diabetes in the first place.  How do we do that?  Strategies include regular physical activity, avoidance or reversal of overweight and obesity, and low-glycemic-index diets.

The Mediterranean diet it linked to reduced heart attacks and strokes, and longer lifespan.  That’s why I’ve been working for the last year and a half to adapt it for diabetics.

ResearchBlogging.orgWe have better treatments for cardiovascular disease and diabetes and these days, so the death rates and illness numbers shouldn’t  be quite so alarming.  Up-to-date management of diabetes and cardiovascular disease will prevent some acute disease events—such as heart attacks and strokes—and prolong life.   

Steve Parker, M.D.

References: 

Franco, O., Steyerberg, E., Hu, F., Mackenbach, J., & Nusselder, W. (2007). Associations of Diabetes Mellitus With Total Life Expectancy and Life Expectancy With and Without Cardiovascular Disease Archives of Internal Medicine, 167 (11), 1145-1151 DOI: 10.1001/archinte.167.11.1145

Knowler, W.C., et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.  New England Journal of Medicine, 346 (2002): 393-403.

Tuomilehto, J., et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.  New England Journal of Medicine, 344 (2001): 1,343-1,350.

1 Comment

Filed under coronary heart disease, Diabetes Complications, Stroke

Rosiglitazone Severely Restricted by FDA

MedPageToday reported yesterday on the U.S. Food & Drug Administration’s ruling that the diabetes drug rosiglitazone should be used in new patients only if blood sugars are not controlled with other diabetes drugs, such as pioglitazone.

It sounds as if new users and their doctors may have to jump through some paperwork hoops to get the drug, which is more reason not to prescribe it.

The problem is that scientific studies suggest that rosiglitazone increases the risk of heart attack, heart failure, and death.

Steve Parker, M.D.

3 Comments

Filed under Diabetes Complications, Drugs for Diabetes

Myth Busted: Alzheimer Dementia NOT Caused By Diabetes

Contrary to popular belief among the experts, type 2 diabetes is not one of the causes of Alzeimer dementia.  They may indeed be associated with each other, but that’s not causation. 

Brain CT scan

An oft-repeated theory from Gary Taubes 2007 masterpiece, Good Calories, Bad Calories, is that many of the chronic diseases of modern civilization, including Alzheimer disease, are caused by abnormal blood sugar and insulin metabolism.  Especially high insulin levels induced by a diet rich in refined carbohydrates.  If that’s the case, you’d expect to see a high prevalence of Alzheimer disease in older type 2 diabetics. 

Dr. Emily Deans (psychiatrist) has been considering this issue recently at her Evolutionary Psychiatry blog.

The brains of Alzheimer patients, under a microscope, are characterized by many senile plaques (aka neuritic plaques) and neurofibrillary tangles.  That’s the gold standard for diagnosis.  Nevertheless, brain biopsies are rarely done to diagnose Alzheimer disease in living patients, and even autopsies after death are rare.  The diagnosis usually is clinical, based on ruling out other illnesses, etc.

Nearly all the studies associating diabetes with Alzheimers disease (and other dementias) are observational or epidimiologic. [The exception is the Honolulu-Asia Aging Study.]  Establishing an association is helpful in generating theories, but establishing causation is the goal.  At least five studies confirm an association.

Neurology this year reported findings of Japanese researchers who examined the brains of 135 people who died between 1998 and 2003.  They lived in Hisayama, a town with an incredibly high autopsy rate of 74%.  These people before death had undergone an oral glucose tolerance test.  Their insulin resistance was calculated on the basis of fasting glucose and fasting insulin (HOMA-IR).  None of them showed signs of dementia at the time of study enrollment in 1988.

What Did They Find?

Twenty-one of the 135 subjects developed Alzheimer-type dementia.  The investigators don’t say if the diagnosis was based on the brain examination, or just a clinical diagnosis without a brain biopsy.  How this got beyond the article reviewers is beyond me.  [If I’m missing something, let me know in the comments section below.]  It must be a clinical diagnosis because if you don’t act demented, it doesn’t matter how many senile plaques and neurofibrillary tangles you have in your brain. 

ResearchBlogging.orgSenile plaques, but not neurofibrillary tangles, were more common  in those with higher levels of blood sugar (as measured two hours after the 75 g oral glucose dose), higher fasting insulin, and higher insulin resistance.  People with the APOE epsilon-4 gene were at even higher risk for developing senile plaques.

The researchers did not report whether the subjects in this study had been previously during life with diabetes or not.  One can only hope those data will be published in another paper.  Why make us wait? 

Average fasting glucose of all subjects was 106 mg/dl (5.9 mmol/l); average two-hour glucose after the oral glucose load was 149 mg/dl (8.3 mmol/l).  By American Association of Clinical Endocrinologists criteria, these are prediabetic levels.  Mysteriously, the authors fail to mention or discuss this.  [I don’t know if AACE criteria apply to Japanese.]  Some of these Japanese subjects probably had diabetes, some had prediabetes, others had normal glucose and insulin metabolism.

As with all good research papers, the authors compare their findings with similar published studies.  They found one autopsy study that tended to agree with their findings (Honolulu) and three others that don’t (see references below).  In fact, one of the three indicated that diabetes seems to protect against the abnormal brain tissue characteristic of Alzheimer disease.

Botton Line

Type 2 diabetes doesn’t seem to be a cause of Alzheimer disease, if autopsy findings and clinical features are the diagnostic criteria for the disease. 

If we assume that type 2 diabetics have higher than normal blood sugar levels and higher insulin levels for several years, then hyperglycemia and hyperinsulinemia don’t cause or contribute to Alzheimer dementia.  Myth busted.  [I hope that’s not copyrighted by the “Myth Busters” TV show.]

Type 2 diabetes is, however, linked with impaired cognitive performance, at least according to many of the scientific articles I read in preparation for this post.  So type 2 diabetics aren’t in the clear yet.  It’s entirely possible that high blood sugar and /or insulin levels cause or contribute to that.  [Any volunteers to do the literature review?  Best search term may be “mild cognitive impairment.”]

Type 2 diabetes is associated with Alzheimer disease, but we have no proof that diabetes is a cause of Alzheimers.  Nor do we have evidence that high blood sugar and insulin levels cause Alzheimer disease. 

Alzheimer disease is a major scourge on our society.  I’d love to think that carbohydrate-restricted eating would help keep blood sugar and insulin levels lower and thereby lessen the devastation of the disease.  Maybe it does, but I’d like to see more convincing evidence.  It’ll be years before we have a definitive answer. 

Steve Parker, M.D.

References:
Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki SO, Kanba S, Kiyohara Y, & Iwaki T (2010). Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology, 75 (9), 764-70 PMID: 20739649

Heitner, J.,  et al. “Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects: a retrospective postmortem immunocytochemical and histofluorescent study.” Neurology, 49 (1997): 1306-1311.  Autopsy study, No. of subjects not in abstract. They looked for senile plaques and neurofibrillary tangles, etc. The title says it all.

Beeri,  M.S., et al. “Type 2 diabetes is NEGATIVELY [emphasis added] associated with Alzheimer’s disease neuropathology.” J. Gerontol A. Biol Sci. Med. Sci. 60 (2005): 471-475.  385 autopsies. The title again says it all.

Arvanitakis, Z., et al. “Diabetes is related to cerebral infarction but NOT [emphasis added] to Alzheimers disease pathology in older persons.”  Neurology, 67 (2006): 1960-1965. Autopsy study of 233 Catholic clergy, about 50:50 women:men.

8 Comments

Filed under Carbohydrate, Diabetes Complications

Chocolate Fights Heart Failure

My recent post at the Self/NutritionData Heart Health Blog outlines late-breaking evidence that chocolate seems to reduce both deaths and hospitalizations from heart failure among women.

You’ll also find my thoughts on milk versus dark chocolate and the healthy “dose.”

Steve Parker, M.D.

3 Comments

Filed under Diabetes Complications

Difficulty Controlling Blood Sugar? Consider Diabetic Gastroparesis

One disorder I see fairly frequently in the hospital is diabetic gastroparesis.  It’s a condition in which the stomach doesn’t empty its contents as quickly into the small intestine (duodenum) as it should.  The nerves that tell the stomach muscles to contract aren’t working properly.  It’s a type of neuropathy.

With gastroparesis, food absorption—including carbohydrates—is slower than usual.  Not only that, if you take pills to lower your sugar, their absorption into the blood stream will also be delayed.

As a result, blood sugars in affected type 1 and type 2 diabetics are difficult to control.  The expected rise in blood sugar after a carb-containing meal is difficult to predict—a major problem if you just injected a rapid-acting insulin!  Oral medication effects are also erratic. 

The frequency of diabetic gastroparesis is unclear.  No doubt it’s more common in people who’ve had diabetes for years, and in type 1 diabetics.

How Is Gastroparesis Diagnosed?

Other than erratic, unexplained poor blood sugar control, are there any other clues to diagnosis?  Symptoms suggestive of gastroparesis include early satiety, abdominal bloating, after-meal fullness, nausea, and vomiting.

The most common diagnostic test for gastroparesis is done at a radiology facility.  The patient eats a meal containing a radioactive chemical called (99m)technetium.  A special camera takes a picture of the stomach after two and four hours to see if the meal has moved on into the small intestine in a timely fashion.

What’s the Treatment for Gastroparesis?

Best to work with your personal physician on that.  It’s not real straightforward, but there is treatment involving meal composition and timing, timing of medications, and drugs to speed up stomach emptying.

Steve Parker, M.D.

Comments Off on Difficulty Controlling Blood Sugar? Consider Diabetic Gastroparesis

Filed under Diabetes Complications

Metformin Raises Risk of Vitamin B-12 Deficiency

ResearchBlogging.orgA recent study out of the Netherlands shows that type 2 diabetics taking insulin and metformin are at risk of clinically significant vitamin B12 deficiency.

B12 deficiency may cause anemia, nerve damage (neuropathy), and dementia, among other problems.

Metformin is the cornerstone of drug therapy for type 2 diabetes.  One reason is that it’s associated with improved cardiovascular disease outcomes—a claim few diabetic drugs can make.  Prior studies established that metformin interferes with B12 absorption.  The study at hand indicates that such malabsorption can reach a clinically significant degree, and that the falling blood levels are progressive over time.

No B12 here

How Was the Study Done?

Three diabetes clinic in the Netherlands provided 390 patients with type 2 diabetes between the ages of 30 and 80.  They were all treated with 1) insulin and metformin 850 mg three times daily, or 2) insulin and placebo three times daily.  B12 levels were drawn periodically over the course of the 4-year study.  Seventy-two percent of participants completed the study (the drop-outs included 30 on metformin and 16 on placebo).

What Did the Investigators Find After Four Years?

  • Compared with the placebo group, B12 levels in the metformin group dropped an average of 19%.
  • Compared to the placebo group, the metformin cohort had a 7% risk of developing B12 deficiency (blood level under 150 pmol/l) and 11% risk of dropping into the “low B12” category (level 150-220 pmol/l).

Clinical Implications

It’s unclear whether these findings apply to diabetics not taking insulin or to other ethnicities and nationalities.  I suspect they do.

The risk of developing B12 deficiency with metformin is not huge, but it seems to be real.  Once B12 deficiency does it’s damage, it may not be totally reversible.  So it’s important to know about this issue if you take or prescribe metformin.  At this point I wouldn’t depend on my doctor to be aware of this adverse drug effect, nor to remember to check B12 levels periodically.

The researchers recommend that B12 levels be checked “regularly” in patients taking metformin, without defining a time frame.  I suggest every year or two—closer to yearly if the patient has other risk factors for B12 deficiency, such as malnutrition, advanced age, removal of part of the stomach, some weight-loss surgeries, vegan diet, celiac disease, and Crohn’s disease.

Steve Parker, M.D.

de Jager, J., Kooy, A., Lehert, P., Wulffele, M., van der Kolk, J., Bets, D., Verburg, J., Donker, A., & Stehouwer, C. (2010). Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial BMJ, 340 (may19 4) DOI: 10.1136/bmj.c2181

2 Comments

Filed under Diabetes Complications, Drugs for Diabetes

Whole Grains Reduce Heart Attacks and Strokes

Whole grain consumption is associated with a 21% reduction in cardiovascular disease when compared to minimal whole grain intake, according to a 2008 review article in Nutrition, Metabolism, and Cardiovascular Disease.   

Coronary heart disease is the No. 1 killer in the developed world.  Stroke is No. 3.  The term “cardiovascular disease” lumps together heart attacks, strokes, high blood pressure,  and generalized atherosclerosis (hardening of the arteries). 

Investigators at Wake Forest University reviewed seven pertinent studies looking at whole grains and cardiovascular disease.  The studies looked at groups of people, determining their baseline food consumption via questionnaire, and noted disease development over time.  These are called “prospective cohort studies.” 

None of these cohorts was composed purely of diabetics.

The people eating greater amounts of whole grain (average of 2.5 servings a day) had 21% lower risk of cardiovascular disease events compared to those who ate an average of 0.2 servings a day.  Disease events included heart disease, strokes, and fatal cardiovascular disease.  The lower risk was similar in degree whether the focus was on heart disease, stroke, or cardiovascular death.

Note that refined grain consumption was not associated with cardiovascular disease events. 

Why does this matter?

The traditional Mediterranean diet is rich in whole grains, which may help explain why the diet is associated with lower rates of cardiovascular disease.  If we look simply at longevity, however, a recent study found no benefit to the cereal grain component of the Mediterranean diet.  Go figure . . . doesn’t add up. 

Readers here know that over the last four months I’ve been reviewing the nutritional science literature that supports the disease-suppression claims for consumption of fruits, vegetables, and legumes.  I’ve been disappointed.  Fruit and vegetable consumption does not lower risk of cancer overall, nor does it prevent heart disease.  I haven’t found any strong evidence that legumes prevent or treat any disease, or have an effect on longevity.  Why all the literature review?  I’ve been deciding which healthy carbohydrates diabetics and prediabetics should add back into their diets after 8–12 weeks of the Ketogenic Mediterranean Diet.

The study at hand is fairly persuasive that whole grain consumption suppresses heart attacks and strokes and cardiovascular death.  [The paleo diet advocates and anti-gluten folks must be disappointed.]  I nominate whole grains as additional healthy carbs, perhaps the healthiest.

But . . .

. . .  for diabetics, there’s a fly in the ointment: the high carbohydrate content of grains often lead to high spikes in blood sugar.  It’s a pity, since diabetics are prone to develop cardiovascular disease and whole grains could counteract that.  We need a prospective cohort study of whole grain consumption in diabetics.  It’ll be done eventually, but I’m not holding my breath.

[Update June 12, 2010: The aforementioned study has been done in white women with type 2 diabetes.  Whole grain and bran consumption do seem to protect them against overall death and cardiovascular death.  The effect is not strong.]

What’s a guy or gal to do with this information now?

Non-diabetics:  Aim to incorporate two or three servings of whole grain daily into your diet if you want to lower your risk of heart disease and stroke. 

Diabetics:  Several options come to mind:

  1. Eat whatever you want and forget about it [not recommended].
  2. Does coronary heart disease runs in your family?  If so, try to incorporate one or two servings of whole grains daily, noting and addressing effects on your blood sugar one and two hours after consumption.  Eating whole grains alone will generally spike blood sugars higher than if you eat them with fats and protein.  Review acceptable blood sugar levels here.
  3. Regardless of family history, try to eat one or two servings of whole grains a day, noting and addressing effects on your blood sugar.  Then decide if it’s worth it.  Do you have to increase your diabetic drug dosages or add a new drug?  Are you tolerating the drugs?  Can you afford them?    
  4. Assess all your risk factors for developing heart disease: smoking, sedentary lifestyle, high blood pressure, age, high LDL cholesterol, family history, etc.  If you have multiple risk factors, see Option #3.  And modify the risk factors under your control.   
  5. Get your personal physician’s advice.    

Steve Parker, M.D.

Extra Credit:  The study authors suggest a number of reasons—and cite pertinent scientific references—how whole grains might reduce heart disease:

  • improved glucose homeostasis (protection against insulin resistance, less rise in blood sugar after ingestion [compared to refined grains], improved insulin sensitivity or beta-cell function)
  • advantageous blood lipid effects (soluble fiber from whole grains [especially oats] reduces LDL cholesterol, lower amounts of the small LDL particles thought to be particularly damaging to arteries, tendency to raise HDL cholesterol and trigylcerides [seen with insulin resistance in the metabolic syndrome])
  • improved function of the endothelial cells lining the arteries (improved vascular reactivity)

Disclaimer:  All matters regarding your health require supervision by a personal physician or other appropriate health professional familiar with your current health status.  Always consult your personal physician before making any dietary or exercise changes.

Reference: Mellen, P.B, Walsh, T.F., and Herrington, D.M.  Whole grain intake and cardiovascular disease: a meta-analysisNutrition, Metabolism and Cardiovascular Disease, 18 (2008): 283-290.

14 Comments

Filed under Carbohydrate, coronary heart disease, Diabetes Complications, Grains, ketogenic diet, legumes, Mediterranean Diet, Stroke

Review: Gestational Diabetes

You can't tell if she has it just by looking

You can’t tell if she has it just by looking

Ever heard of gestational diabetes?  It’s when a when a woman develops diabetes during pregnancy.  It usually goes away soon after the baby is born.  All pregnancies are characterized by some degree of insulin resistance and high insulin levels: they are necessary for the baby.  Nevertheless, healthy pregnant women run blood sugars 20% lower than when they are not pregnant.

In the U.S., gestational diabetes occurs in 5% of pregnancies, affecting more than 240,000 births annually.  Compared to caucasians, gestational diabetes mellitus (GDM) occurs more often in blacks, native Americans, Asians, and Latinos.

So What’s the Big Deal?

Numerous problems are associated with GDM, for both the mother and the baby:

  • dangerously high blood pressure (preeclampsia)
  • excessive amount of amniotic fluid (the baby in the uterus floats in this fluid)
  • delivery requiring an operation
  • early or premature delivery
  • death of the baby
  • birth trauma, such as broken bones or nerve injury
  • metabolic problems in the baby (low blood sugar, for example)
  • abnormally large baby (macrosomia, a major problem)

Diabetic ketoacidosis—a life-threatening complication of diabetes—is rare in GDM.

How Is GDM Diagnosed?  (section updated December 28, 2013)

Most women should undergo a screening test around the 24th to 28th week of pregnancy.  Screen earlier if undiagnosed type 2 diabetes is suspected or if risk factors for diabetes are present.  The American Diabetes Association (2014 guidelines) recommends either one of two screening tests.

  • “One-step test.” It’s a morning oral glucose tolerance test after at least eight hours of fasting. Fasting blood sugar is tested then he woman drinks 75 grams oral of glucose.  Blood sugar is tested again one and two hours later.  This blood sample is obtained by a needle in a vein, not by finger prick.  Gestational diabetes is diagnosed if any of the following apply: 1) fasting glucose is 92 mg/dl (5.1 mmol/l) or higher, 2) 0ne-hour level is 180 mg/dl (10.0 mmol/l) or higher, or 3) two-hour level is 153 mg/dl (8.5 mmol/l) or higher.
  • “Two-step test.” This is a nonfasting test with only one needle-stick. The woman drinks 50 grams of glucose; plasma glucose is tested one hour later. But if it’s over 140 mg/dl (10.0 mmol/l), that’s a flunk and a three-hour 100-gram oral glucose tolerance test in the fasting state must be done (step two). Gestational diabetes is present if the three-hour glucose is 140 mg/dl (7.8 mmol/l) or higher. Other experts say the diagnosis requires two or more of the following:
    • fasting blood sugar > 95 mg/dl (5.3 mmol/l)
    • 1-hour blood sugar > 180 mg/dl (10 mmol/l)
    • 2-hour blood sugar > 155 mg/dl (8.6 mmol/l)
    • 3-hour blood sugar > 140 mg/dl (7.8 mmol/l)

You’ll find that various expert panels have proposed different criteria for the diagnosis. The National Institutes of Health in the U.S. published their consensus statement in 2013

There’s no need for the screening test if a random blood sugar is over 200 mg/dl (11.1 mmol/l) or a fasting sugar is over 126 mg/dl: those numbers already define diabetes, assuming they are confirmed with a second high reading.  A random blood sugar over 200 mg/dl (11.1 mmol/l) should probably be repeated for confirmation.  Gestational diabetes can be diagnosed at the first prenatal visit if fasting blood sugar is 92 or over mg/dl (5.1 mmol/l or over) but under 126 mg/dl (7 mmol/l), or if hemoglobin A1c at the first prenatal visit is 6.5% or greater.

Women with diabetes in the first trimester have overt diabetes, not gestational diabetes.

What’s the Treatment for Gestational Diabetes?

Briefly: diet, exercise, blood glucose self-monitoring,  and insulin if needed.  The immediate goal is to achieve normal blood sugars.

A registered dietitian is involved in teaching diet modification.  The standard recommendation is to reduce carbohydrate consumption to 35-40% of total calories.  [By comparison, the standard American diet provides about 55% of calories as carbohydrates.]  Protein and fat are about 20% and 40%, respectively.  Total calorie recommendations are based on the mother’s ideal body weight.  Insulin resistance is greatest in the morning, so breakfast is small.  Complex carbohydrates are favored over simple sugars.  Most women will achieve normal glucose (blood sugar) levels with diet modification.

Moderate exercise also helps control blood sugars, partially by increasing sensitivity of body tissues to insulin.

How often should blood sugar be monitored by the mother?  Ideally, at least four times daily: fasting (on an empty stomach before breakfast) and one hour after the first bite of each meal.

Insulin therapy should be seriously considered when fasting glucose is over 90–95 mg/dl (5.0–5.3 mmol/l) or 1-hour-after-meal glucose is over 120-130 mg/dl (6.7–7.2 mmol/l).  Fifteen percent of mothers with GDM will need insulin injections.  If elevated fasting glucose is the only problem, NPH insulin before bedtime is prescribed.  If sugar levels one hour after meals are elevated, then use rapid-acting insulin aspart or insulin lispro just before meals.  In some cases, both NPH and rapid-acting insulin are both necessary.

Outside the U.S., glucose-lowering pills are sometimes used: glyburide and/or metformin most commonly.

What About After Delivery?

Having had gestational diabetes, the mother is at high risk of developing typical non-pregnant diabetes in the future. She should be screened for the development of diabetes and prediabetes at least every three years. Regular exercise and loss of excess weight decrease the risk substantially.

Steve Parker, M.D.

Sources:  UpToDate.com article on gestational diabetes, accessed March, 2010 and October, 2011.  American College of Obstetrics and Gynecology position paper published in 2001.  Diabetes Care, vol. 34, 2011: supplement 1: S62.  Blood sugar levels on the 3-hour 100-gram glucose tolerance test are from the Fourth International Workshop-Conference on Gestational Diabetes, published in 2000. For gestational diabetes diagnosis: American Diabetes Association’s Standards of Care in Diabetes – 2014.

8 Comments

Filed under Diabetes Complications, Prevention of T2 Diabetes

How Well Should Diabetes Be Controlled?

Researchers in the U.K. suggest that a hemoglobin A1c of 7.5% may be optimal in terms of longevity for type 2 diabetics treated with drugs, according to a study published recently in The Lancet.

Hemoglobin A1c (HgbA1c) is a blood test widely used as a gauge of blood sugar control, reflecting average blood sugars over the previous three months.  The American Diabetes Association recommends a HgbA1c goal of 7% or less.  The American Association of Clinical Endocrinologists recommends 6.5% or less.  Dr. Richard K. Bernstein, a diabetologist and himself a type 1 diabetic, recommends HgbA1c’s as near normal as possible (about 5%). 

Many physicians believe that keeping blood sugar levels as close to normal as possible—often referred to as “tight control”— will help prevent certain diabetes complications such as blindness, kidney failure, and nerve damage.  We have good supportive evidence.

We assume tight control would also help prevent premature death from heart attacks and strokes, too.  Several recent studies—the ACCORD and ADVANCE trials—call this into question, however.  The ACCORD trial, for example, achieved near-normal glucose control with multiple medication options, yet found that the effort was linked to increased death rates from cardiovascular disease and from any cause (all-cause mortality).

The scariest thing about tight control is hypoglycemia, which can kill you quickly, for example,  if you’re operating dangerous machinery (e.g., driving), scuba-diving, or rock-climbing.

U.K. researchers recently reviewed records of diabetics treated either with 1) two oral medications (usually metformin and a sulfonylurea), or 2) a regimen containing insulin.  Each group had over 20,000 subjects.  They found that risk of death for those with an average HgbA1c of 6.4% (the lowest blood sugar levels in this study) was 52% higher than those with HgbA1c of 7.5%.  Those with the highest blood sugar levels over time—HgbA1c over 10% if I recall correctly—had the highest risk of death.  In general, those taking insulin had higher rates of death than those on pills.

It’s extremely difficult to interpret studies like this.  There are myriad ways to treat diabetes.  We have 10 classes of drugs for treatment of diabetes: this study looked at three.  There are at least three types of “diabetic diet” in common use: low-fat/high-carb, low-carb, and just regular eating, which depends on where you live.  Exercise, too, plays a role in treatment and longevity. 

With all these variables, should we put much stock in a study that looks at longevity from the perspective of just two therapeutic regimens?  How well would a football team do with just two plays in its play-book?

You’d think we would have a definite answer to the “tight versus loose control” issue by 2010.  We don’t.  It’s still very appealing to me to think that, if done right, tight control would yield the better outcomes.  Problem is, we don’t always know what’s right. 

One thing is clear: Having a HgbA1c of 7.5% is better than 10% in terms of health and longevity. 

But is 7.5% really better than 6.5 or 5.5 or 5.0% for a particular individual on a particular treatment program?  Probably not.  That’s why the ADA and AACE emphasize that treatment programs be tailored to the individual patient.        

Maybe controlling blood sugar levels is like controlling high blood pressure.  The ideal may be 120/80, but you gain very little, if any, by reducing high blood pressure below 140/90 (130/85 for diabetics).  HgbA1c of 5.0% may be ideal, but not necessary.

Steve Parker, M.D. 

References:

Currie, Craig, et al.  Survival as a function of HgA1c in people with type 2 diabetes: a retrospective cohort study.  The Lancet, January 27, 2010.  Early online publication   doi: 10.1016/S0140-6736(09)61969-3

Dluhy, Robert and McMahon, Graham.  Intensive glycemic control in the ACCORD and ADVANCE trials.  New England Journal of Medicine, 358 (2008):2630-2633.

1 Comment

Filed under Diabetes Complications, Drugs for Diabetes

Grains and Legumes: Any Effect on Heart Disease and Stroke?

Several scientific studies published in the first five years of this century suggest that whole grain consumption protects agains coronary heart disease and possibly other types of cardiovascular disease, such as stroke. 

Note that researchers in this field, especially outside the U.S., use the term “cereal” to mean “a grass such as wheat, oats, or corn, the starchy grains of which are used as food.”  They also refer frequently to glycemic index and glycemic load, spelled “glycaemic” outside the U.S.  Most of the pertinent studies are observational (aka epidmiologic): groups of people were surveyed on food consumption, then rates of diseases were associated with various food types and amounts.  “Association” is not proof of causation. 

Here are highlights from a 2006 review article in the European Journal of Clinical Nutrition

The researchers concluded that a relationship between whole grain intake and coronary heart disease is seen with at least a 20% and perhaps a 40% reduction in risk for those who eat whole grain food habitually vs those who eat them rarely.

Whole grain products have strong antioxidant activity and contain phytoestrogens, but there is insufficient evidence to determine whether this is beneficial in coronary heart disease prevention.

Countering the positive evidence for whole grain and legume intake has been the Nurses Health Study in 2000 that showed women who were overweight or obese consuming a high glycaemic load (GL) diet doubled their relative risk of coronary heart disease compared with those consuming a low GL diet.

The intake of high GI carbohydrates (from both grain and non-grain sources) in large amounts is associatied with an increased risk of heart disease in overweight and obese women even when fiber intake is high but this requires further confirmation in normal-weight women.

Promotion of carbohydrate foods should befocused on whole grain cereals because these have proven to be associatied with health benefits.

Whether adding bran to refined carbohydrate foods can improve the situation is also not clear, and it was found that added bran lowered heart disease risk in men by 30%.

Recommendation:  Carbohydrate-rich foods should be whole grain and if theyare not, then the lowest GI product available should be consumed.

My Comments

This journal article focuses on whole grains rather than legumes, and promotes whole grains more than legumes.  For people with diabetes, this may be a bit of a problem since grains—whole or not—generally have a higher glycemic index than legumes, which may have adverse effects on blood sugar control.  Keep in mind that highly refined grain products, like white bread, have a higher glycemic index than whole grain versions.

Did you notice that the abstract doesn’t recommend a specific amount of whole grains for the general population?  My educated guess would be one or two servings a day. 

Grains are high in carbohydrate, so anyone on a low-carb diet may have to cut carbs elsewhere. 

Diabetes predisoses to development of coronary heart disease.  Whole grains seem to help prevent heart disease, yet may adversely affect glucose control, contributing to diabetic complications.  It’s a quandary.  “Caught between the horns of a dilemma,” you might say.  So, what should a diabetic do with this information in 2010, while we await additional research results?

Several options come to mind:

  1. Eat whatever you want and forget about it.
  2. Note whether coronary heart disease runs in your family.  If so, try to incorporate one or two servings of whole grains daily, noting and addressing effects on your blood sugar.
  3. Try to eat one or two servings of whole grains a day, noting and addressing effects on your blood sugar.  Then decide if it’s worth it.  Is there any effect?  Do you have to increase your diabetic drug dosages or add a new drug?  Are you tolerating the drugs?    
  4. Assess all your risk factors for developing heart disease: smoking, sedentary lifestyle, high blood pressure, age, high LDL cholesterol, family history, etc.  If you have multiple risk factors, see Option #3.  And modify the risk factors under your control.   
  5. Get your personal physician’s advice.    

Before you stress out over this, be aware that we don’t really know whether a diabetic who doesn’t eat grains will have a longer healthier life by starting a daily whole grain habit.  Maybe . . . maybe not.  The study hasn’t been done.    

Steve Parker, M.D.

References:

Flight, I. and Clifton, P.  Cereal grains and legumes in the prevention of coronary heart disease and stroke: a review of the literatureEuropean Journal of Clinical Nutrition, 60 (2006): 1,145-1,159.

Malik, V. and Hu, Frank.  Dietary prevention of atherosclerosis: go with whole grainsAmerican Journal of Clinical Nutrition, 85 (2007): 1,444-1,445.

4 Comments

Filed under Carbohydrate, coronary heart disease, Diabetes Complications, Grains, legumes, Stroke